A detailed history of Chilton Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Chilton Capital Management LLC holds 13,481 shares of ABBV stock, worth $2.42 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
13,481
Previous 13,704 1.63%
Holding current value
$2.42 Million
Previous $2.35 Million 13.28%
% of portfolio
0.11%
Previous 0.11%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $36,536 - $44,450
-223 Reduced 1.63%
13,481 $2.66 Million
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $37,149 - $43,382
240 Added 1.78%
13,704 $2.35 Million
Q1 2024

May 07, 2024

SELL
$159.82 - $182.1 $193,701 - $220,705
-1,212 Reduced 8.26%
13,464 $2.45 Million
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $10,044 - $11,312
73 Added 0.5%
14,676 $2.27 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $64,123 - $74,232
-480 Reduced 3.18%
14,603 $2.18 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $54,329 - $67,609
410 Added 2.79%
15,083 $2.03 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $1,446 - $1,665
-10 Reduced 0.07%
14,673 $2.34 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $33,747 - $40,472
-244 Reduced 1.63%
14,683 $2.37 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $22,949 - $26,322
-171 Reduced 1.13%
14,927 $2 Million
Q2 2022

Aug 16, 2022

SELL
$137.62 - $174.96 $231,063 - $293,757
-1,679 Reduced 10.01%
15,098 $2.31 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $395 - $491
-3 Reduced 0.02%
16,777 $2.72 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $537 - $679
-5 Reduced 0.03%
16,780 $2.27 Million
Q3 2021

Nov 04, 2021

SELL
$106.4 - $120.78 $5,320 - $6,039
-50 Reduced 0.3%
16,785 $1.81 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $43,451 - $48,407
413 Added 2.51%
16,835 $1.9 Million
Q1 2021

May 12, 2021

SELL
$102.3 - $112.62 $818 - $900
-8 Reduced 0.05%
16,422 $1.78 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $4,587 - $6,194
-57 Reduced 0.35%
16,430 $1.76 Million
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $1.03 Million - $1.21 Million
12,000 Added 267.44%
16,487 $1.44 Million
Q2 2020

Aug 11, 2020

SELL
$73.37 - $98.18 $10,932 - $14,628
-149 Reduced 3.21%
4,487 $441,000
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $30,637 - $46,450
-475 Reduced 9.29%
4,636 $353,000
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $19,835 - $24,818
-275 Reduced 5.11%
5,111 $453,000
Q3 2019

Nov 15, 2019

SELL
$62.98 - $75.72 $18,894 - $22,716
-300 Reduced 5.28%
5,386 $408,000
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $29,565 - $37,791
450 Added 8.59%
5,686 $413,000
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $78,706 - $97,066
-1,011 Reduced 16.18%
5,236 $483,000
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $218,718 - $243,146
-2,460 Reduced 28.25%
6,247 $591,000
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $228,220 - $270,036
2,542 Added 41.23%
8,707 $807,000
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $336,296 - $450,332
-3,655 Reduced 37.22%
6,165 $584,000
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $3,582 - $3,928
-40 Reduced 0.41%
9,820 $950,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $688,721 - $879,709
9,860
9,860 $876,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Chilton Capital Management LLC Portfolio

Follow Chilton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.